Literature DB >> 9831393

Highly efficient recovery of functional single-chain Fv fragments from inclusion bodies overexpressed in Escherichia coli by controlled introduction of oxidizing reagent--application to a human single-chain Fv fragment.

K Tsumoto1, K Shinoki, H Kondo, M Uchikawa, T Juji, I Kumagai.   

Abstract

An improved and efficient refolding system for a single-chain antibody fragment (scFv) from inclusion bodies expressed in Escherichia coli was developed. Stepwise removal of denaturing reagent and controlled addition of oxidizing reagent were found to be the most effective conditions to achieve for almost complete recovery of functional monomeric scFv from inclusion bodies. Adding L-arginine to the refolding solution also increased the yield of refolded functional scFv. The single-chain Fv fragments of both a mouse anti-lysozyme monoclonal antibody, HyHEL10, and a human monoclonal antibody against the D antigen of the Rh blood group, D10, in solubilized inclusion bodies could be refolded under these conditions with yields of up to 95%. The refolding procedures developed in this study will contribute to providing a stable supply of large amounts of human single-chain Fv fragments.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831393     DOI: 10.1016/s0022-1759(98)00127-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  31 in total

1.  Expression, purification, and characterization of recombinant fibulin-5 in a prokaryote expression system.

Authors:  Myoung Seok Jeong; Chang Soo Kang; Yeon Soo Han; In Seok Bang
Journal:  J Microbiol       Date:  2010-11-03       Impact factor: 3.422

2.  Mutations for decreasing the immunogenicity and maintaining the function of core streptavidin.

Authors:  Kyohei Yumura; Mihoko Ui; Hirofumi Doi; Takao Hamakubo; Tatsuhiko Kodama; Kouhei Tsumoto; Akira Sugiyama
Journal:  Protein Sci       Date:  2013-01-04       Impact factor: 6.725

3.  Preparation of biologically active single-chain variable antibody fragments that target the HIV-1 gp120 V3 loop.

Authors:  Y T Ong; K A Kirby; A Hachiya; L A Chiang; B Marchand; K Yoshimura; T Murakami; K Singh; S Matsushita; S G Sarafianos
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2012-12-22       Impact factor: 1.770

4.  The intervening removable affinity tag (iRAT) production system facilitates Fv antibody fragment-mediated crystallography.

Authors:  Yayoi Nomura; Yumi Sato; Ryoji Suno; Shoichiro Horita; So Iwata; Norimichi Nomura
Journal:  Protein Sci       Date:  2016-09-14       Impact factor: 6.725

5.  Paired cloning of the T cell receptor alpha and beta genes from a single T cell without the establishment of a T cell clone.

Authors:  M Kurokawa; J Tong; T Matsui; K Masuko-Hongo; T Yabe; K Nishioka; K Yamamoto; T Kato
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

6.  Ternary system of solution additives with arginine and salt for refolding of beta-galactosidase.

Authors:  Akiko Fujimoto; Atsushi Hirano; Kentaro Shiraki
Journal:  Protein J       Date:  2010-04       Impact factor: 2.371

7.  Tuning Inner-Ear Tip-Link Affinity Through Alternatively Spliced Variants of Protocadherin-15.

Authors:  Yoshie Narui; Marcos Sotomayor
Journal:  Biochemistry       Date:  2018-03-06       Impact factor: 3.162

8.  L-Arginine increases the solubility of unfolded species of hen egg white lysozyme.

Authors:  Ravi Charan Reddy K; Hauke Lilie; Rainer Rudolph; Christian Lange
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

9.  Solubility of disulfide-bonded proteins in the cytoplasm of Escherichia coli and its "oxidizing" mutant.

Authors:  Sheng Xiong; Yi-Fei Wang; Xiang-Rong Ren; Bing Li; Mei-Ying Zhang; Yong Luo; Ling Zhang; Qiu-Ling Xie; Kuan-Yuan Su
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

10.  Trans-cyclohexanediamines prevent thermal inactivation of protein: role of hydrophobic and electrostatic interactions.

Authors:  Atsushi Hirano; Hiroyuki Hamada; Kentaro Shiraki
Journal:  Protein J       Date:  2008-06       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.